Overview of Grant Program
The goal of the PASA Consortium is to fund study applications for developing new medications that can be brought to therapeutic use to improve treatment outcomes for alcohol and substance use disorders (ASUD), especially as related to post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). The PASA Consortium accepts applications for study funding during open solicitation periods. The exact number and type of studies approved during each solicitation period will depend on the quantity and quality of applications received and amount of available funding. Notices of study application solicitation periods will be posted here on the PASA Consortium’s website, publicly advertised via professional organization e-mail list serves and conference postings, and distributed to investigators, pharmaceutical companies, and academic research institutes that are known to have potentially viable candidate compounds. Please check here regularly for funding announcements and updates.
Current Funding Opportunities
All funding opportunities are now closed. Another round will be announced in 2019. Please check later from more information. Below are details about the previous application round for your information.
All funding opportunities are now closed. Another round will be announced in 2019. Please check later from more information.